CCDC102B, which stands for Coiled-Coil Domain Containing 102B, is a protein encoded by the CCDC102B gene in humans. Despite the limited research and lesser-known functions of CCDC102B compared to other proteins, it is thought to participate in cellular processes due to its coiled-coil domain, which is a structural motif known to facilitate protein-protein interactions.The coiled-coil domain of CCDC102B suggests it may be involved in the organization of the cytoskeleton, intracellular trafficking, or the assembly of multi-protein complexes. These domains typically enable proteins to form stable, oligomeric structures, which are essential for a variety of cellular tasks, including vesicle transport, cell division, and signal transduction.
Because proteins with coiled-coil domains often play roles in maintaining cellular structure and facilitating communication between cells and their external environment, CCDC102B might be implicated in these areas. However, the precise functions of CCDC102B have yet to be determined through empirical research.Potential evidence from genomic association studies and expression profiling could imply a role for CCDC102B in certain diseases or developmental processes. For example, changes in the expression levels or mutations within the CCDC102B gene may correlate with specific phenotypes or pathologies, prompting further investigation into the protein's functions.Given the evolutionary conservation of coiled-coil domain-containing proteins, CCDC102B is likely important for normal cellular function, and further research may reveal its involvement in critical biological pathways. Understanding CCDC102B's role could have implications for diseases where cellular organization and signaling are disrupted.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, may indirectly affect CCDC102B by modulating cellular growth and autophagy processes, potentially influencing proteins involved in these pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 can influence various signaling pathways, potentially altering the expression or function of proteins like CCDC102B involved in cellular processes regulated by PI3K. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By inhibiting p38 MAPK, SB203580 could indirectly influence CCDC102B function, as p38 MAPK is a key player in inflammatory responses and stress-induced cellular pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As an inhibitor of PI3K, Wortmannin may alter CCDC102B-related pathways by affecting cellular processes like growth, survival, and metabolism. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an inhibitor of MEK, may indirectly modulate CCDC102B activity by influencing the MAPK/ERK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 might affect CCDC102B indirectly by modulating cellular stress responses and apoptosis pathways. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $265.00 | ||
This ERK1/2 inhibitor potentially impacts CCDC102B indirectly by modulating signaling pathways involved in cell proliferation and differentiation. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
As an mTOR inhibitor like Rapamycin, Torin 1 can indirectly affect the function or expression of CCDC102B by altering cellular growth and autophagy pathways. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $224.00 $386.00 | 5 | |
As a MEK5 inhibitor, BIX 02189 might indirectly influence CCDC102B through pathways involving the ERK5/MAPK7 cascade. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib, a MEK inhibitor, could indirectly affect CCDC102B by modulating the MAPK/ERK pathway, impacting cell growth and differentiation. | ||||||